Sign In
Buy ONTX
$1.00
+0 (+0%)
At Close: Jul 01, 2024
Onconova Therapeutics shares are trading higher after the company reported better-than-expected Q1 EPS results.
12:45pm, Friday, 15'th May 2020Onconova Therapeutics, Inc. (ONTX) CEO Steve Fruchtman on Q1 2020 Results - Earnings Call Transcript
12:33am, Friday, 15'th May 2020
Onconova Therapeutics, Inc. (NASDAQ:ONTX) Q1 2020 Earnings Conference Call May 14, 2020 4:30 PM ET Company Participants Avi Oler - Vice President, Corporate Dev
Onconova Therapeutics Q1 EPS $(0.030) Beats $(0.050) Estimate, Sales $52.000K May Not Compare To $150.000K Estimate
08:17pm, Thursday, 14'th May 2020Onconova Therapeutics Provides Corporate Update and Reports First Quarter 2020 Financial Results
08:05pm, Thursday, 14'th May 2020
NEWTOWN, Pa., May 14, 2020 -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to.
Onconova Therapeutics Announces Virtual Format for 2020 Annual Meeting of Stockholders
12:00pm, Monday, 11'th May 2020
Onconova Therapeutics, Inc. (ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
12:00am, Sunday, 10'th May 2020
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB)...
Onconova Therapeutics to Provide Corporate Update and First Quarter 2020 Earnings on May 14, 2020
12:00pm, Thursday, 07'th May 2020
Onconova Therapeutics, Inc. (ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (
Onconova Therapeutics Strengthens Board of Directors with Nomination of Life Sciences Industry Veteran
12:00pm, Monday, 27'th Apr 2020
Onconova Therapeutics, Inc. (ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (
Russo Partners' Sports-Health Alliance, part of the New York City-based healthcare and technology communications firm, has launched "Stay Safe. Stay Together. Stay Healthy," a social media campaign to
How 3 Philly-area biopharmaceutical firms are working through coronavirus challenges
10:40am, Tuesday, 07'th Apr 2020
Philadelphia-area life science companies say they are continuing their drug development efforts, but they expect to encounter some delays because of workplace restrictions during the coronavirus pande
Edited Transcript of ONTX earnings conference call or presentation 24-Mar-20 8:30pm GMT
11:00am, Thursday, 02'nd Apr 2020
Q4 2019 Onconova Therapeutics Inc Earnings Call
18 Healthcare Stocks Moving In Monday's Pre-Market Session
11:35am, Monday, 30'th Mar 2020
Gainers
• Plus Therapeutics, Inc. (NASDAQ:PSTV) stock surged 38.89% to $2 during Monday's pre-market session.
• Owens & Minor, Inc. (NYSE:OMI) stock moved...
